| NCT04416568 |
Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers |
https://ClinicalTrials.gov/show/NCT04416568 |
Recruiting |
Dana-Farber Cancer Institute |
2023-10-31 |
| NCT03977571 |
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial |
https://ClinicalTrials.gov/show/NCT03977571 |
Recruiting |
University of Aarhus |
2025-09-01 |
| NCT01714765 |
Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer |
https://ClinicalTrials.gov/show/NCT01714765 |
Completed |
Queen Mary University of London |
2012-10-31 |
| NCT03824808 |
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery |
https://ClinicalTrials.gov/show/NCT03824808 |
Recruiting |
University of Missouri-Columbia |
2020-02-01 |
| NCT03819569 |
GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses |
https://ClinicalTrials.gov/show/NCT03819569 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2021-12-30 |
| NCT03357289 |
Mix Vaccine for Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT03357289 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2018-11-30 |
| NCT03354390 |
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03354390 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2020-12-31 |
| NCT03334344 |
Using Virtual Reality (VR) Models for Preoperative Planning |
https://ClinicalTrials.gov/show/NCT03334344 |
Completed |
Ceevra, Inc. |
2019-02-28 |
| NCT03323021 |
Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy |
https://ClinicalTrials.gov/show/NCT03323021 |
Completed |
MiMedx Group, Inc. |
2019-02-21 |
| NCT03289962 |
A Study of RO7198457 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors |
https://ClinicalTrials.gov/show/NCT03289962 |
Recruiting |
Genentech, Inc. |
2020-09-11 |
| NCT03280667 |
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma |
https://ClinicalTrials.gov/show/NCT03280667 |
Recruiting |
Australian and New Zealand Urogenital and Prostate Cancer Trials Group |
2021-04-04 |
| NCT03273751 |
The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy |
https://ClinicalTrials.gov/show/NCT03273751 |
Recruiting |
Seoul National University Hospital |
2019-12-30 |
| NCT03203473 |
Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) |
https://ClinicalTrials.gov/show/NCT03203473 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2020-11-30 |
| NCT03185039 |
Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents |
https://ClinicalTrials.gov/show/NCT03185039 |
Recruiting |
Institut Paoli-Calmettes |
2022-12-13 |
| NCT03165721 |
A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer |
https://ClinicalTrials.gov/show/NCT03165721 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-02-24 |
| NCT03091192 |
Savolitinib vs. Sunitinib in MET-driven PRCC |
https://ClinicalTrials.gov/show/NCT03091192 |
Active, not recruiting |
AstraZeneca |
2019-08-18 |
| NCT03086174 |
Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma |
https://ClinicalTrials.gov/show/NCT03086174 |
Active, not recruiting |
Shanghai Junshi Bioscience Co., Ltd. |
2019-12-31 |
| NCT03073395 |
Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer |
https://ClinicalTrials.gov/show/NCT03073395 |
Recruiting |
Five Eleven Pharma, Inc. |
2020-10-20 |
| NCT03066427 |
Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment. |
https://ClinicalTrials.gov/show/NCT03066427 |
Recruiting |
Spanish Oncology Genito-Urinary Group |
2020-12-31 |
| NCT03065179 |
Trial of SBRT in Combination With Nivolumab/Ipilimumab in RCC / Kidney Cancer Patients |
https://ClinicalTrials.gov/show/NCT03065179 |
Recruiting |
University of Texas Southwestern Medical Center |
2020-01-31 |
| NCT03064308 |
The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery |
https://ClinicalTrials.gov/show/NCT03064308 |
Completed |
University of Nottingham |
2018-07-26 |
| NCT03062410 |
Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03062410 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2019-11-04 |
| NCT03053466 |
APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors |
https://ClinicalTrials.gov/show/NCT03053466 |
Active, not recruiting |
Apollomics (Australia) Pty. Ltd. |
2020-02-29 |
| NCT03024437 |
Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03024437 |
Recruiting |
Indiana University |
2020-01-31 |
| NCT03015740 |
Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT03015740 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2023-04-23 |
| NCT02994758 |
Development of Diagnostics and Treatment of Urological Cancers |
https://ClinicalTrials.gov/show/NCT02994758 |
Recruiting |
Helsinki University Central Hospital |
2020-12-31 |
| NCT02992912 |
Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours |
https://ClinicalTrials.gov/show/NCT02992912 |
Recruiting |
Gustave Roussy, Cancer Campus, Grand Paris |
2020-10-31 |
| NCT02988219 |
Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method |
https://ClinicalTrials.gov/show/NCT02988219 |
Completed |
Medical University of Warsaw |
2014-12-31 |
| NCT02966509 |
Engagement of Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT02966509 |
Completed |
Stanford University |
2016-12-31 |
| NCT02964078 |
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT02964078 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2019-03-26 |
| NCT02950766 |
A Study Combining NeoVax, a Personalized NeoAntigen Cancer Vaccine, With Ipilimumab to Treat High-risk Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02950766 |
Recruiting |
Dana-Farber Cancer Institute |
2021-06-30 |
| NCT02947165 |
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. |
https://ClinicalTrials.gov/show/NCT02947165 |
Recruiting |
Novartis |
2021-04-13 |
| NCT02946671 |
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients |
https://ClinicalTrials.gov/show/NCT02946671 |
Completed |
Osaka University |
2020-03-31 |
| NCT02928692 |
Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium |
https://ClinicalTrials.gov/show/NCT02928692 |
Recruiting |
RenJi Hospital |
2021-12-31 |
| NCT02924922 |
Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy |
https://ClinicalTrials.gov/show/NCT02924922 |
Completed |
Luzerner Kantonsspital |
2018-12-31 |
| NCT02897778 |
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02897778 |
Completed |
Syndax Pharmaceuticals |
2017-03-31 |
| NCT02890069 |
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat |
https://ClinicalTrials.gov/show/NCT02890069 |
Recruiting |
Novartis |
2021-05-28 |
| NCT02875548 |
Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study |
https://ClinicalTrials.gov/show/NCT02875548 |
Recruiting |
Epizyme, Inc. |
2023-12-31 |
| NCT02862288 |
Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. |
https://ClinicalTrials.gov/show/NCT02862288 |
Completed |
Centre Hospitalier Universitaire de Besancon |
2015-02-28 |
| NCT02812420 |
Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery |
https://ClinicalTrials.gov/show/NCT02812420 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-03-31 |
| NCT02811250 |
Stereotactic Radiotherapy for Renal Cancers |
https://ClinicalTrials.gov/show/NCT02811250 |
Active, not recruiting |
Hospices Civils de Lyon |
2018-02-28 |
| NCT02762006 |
Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02762006 |
Active, not recruiting |
Case Comprehensive Cancer Center |
2020-11-06 |
| NCT02734329 |
Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage |
https://ClinicalTrials.gov/show/NCT02734329 |
Recruiting |
RenJi Hospital |
2020-09-30 |
| NCT02713269 |
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord |
https://ClinicalTrials.gov/show/NCT02713269 |
Recruiting |
M.D. Anderson Cancer Center |
2022-07-01 |
| NCT02689167 |
Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02689167 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2020-02-29 |
| NCT02687139 |
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02687139 |
Completed |
Johns Hopkins University |
2019-04-30 |
| NCT02685553 |
Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project |
https://ClinicalTrials.gov/show/NCT02685553 |
Completed |
Universita di Verona |
2016-10-31 |
| NCT02643303 |
A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers |
https://ClinicalTrials.gov/show/NCT02643303 |
Recruiting |
Ludwig Institute for Cancer Research |
2022-08-31 |
| NCT02613819 |
Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney |
https://ClinicalTrials.gov/show/NCT02613819 |
Active, not recruiting |
Trans-Tasman Radiation Oncology Group (TROG) |
2020-03-02 |
| NCT02601950 |
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma |
https://ClinicalTrials.gov/show/NCT02601950 |
Recruiting |
Epizyme, Inc. |
2023-05-31 |
| NCT02597322 |
Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN) |
https://ClinicalTrials.gov/show/NCT02597322 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2015-11-30 |
| NCT02019693 |
A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT02019693 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-06-30 |
| NCT03408652 |
Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies |
https://ClinicalTrials.gov/show/NCT03408652 |
Active, not recruiting |
Centre Leon Berard |
2021-06-30 |
| NCT02465060 |
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) |
https://ClinicalTrials.gov/show/NCT02465060 |
Recruiting |
National Cancer Institute (NCI) |
2022-06-30 |
| NCT03175224 |
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03175224 |
Recruiting |
Apollomics Inc. |
2021-09-30 |
| NCT02496208 |
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors |
https://ClinicalTrials.gov/show/NCT02496208 |
Recruiting |
National Cancer Institute (NCI) |
2020-09-30 |
| NCT02495103 |
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02495103 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-02-06 |
| NCT02465892 |
Pillars4Life Trial |
https://ClinicalTrials.gov/show/NCT02465892 |
Completed |
Duke University |
2016-10-31 |
| NCT02431676 |
Survivorship Promotion In Reducing IGF-1 Trial |
https://ClinicalTrials.gov/show/NCT02431676 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2018-12-31 |
| NCT02412670 |
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer |
https://ClinicalTrials.gov/show/NCT02412670 |
Active, not recruiting |
Eastern Cooperative Oncology Group |
2020-02-29 |
| NCT02348008 |
Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma: |
https://ClinicalTrials.gov/show/NCT02348008 |
Active, not recruiting |
Big Ten Cancer Research Consortium |
2020-06-30 |
| NCT02335827 |
Irreversible Electroporation(IRE) For Unresectable Renal Tumors |
https://ClinicalTrials.gov/show/NCT02335827 |
Recruiting |
Fuda Cancer Hospital, Guangzhou |
2020-05-20 |
| NCT02306954 |
Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer |
https://ClinicalTrials.gov/show/NCT02306954 |
Recruiting |
Providence Health & Services |
2022-01-31 |
| NCT02295982 |
Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i.e.: Are There Differences in Postoperative Outcome / Convalescence) |
https://ClinicalTrials.gov/show/NCT02295982 |
Completed |
Zealand University Hospital |
2016-05-31 |
| NCT02293980 |
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02293980 |
Active, not recruiting |
Peloton Therapeutics, Inc. |
2021-11-30 |
| NCT02292914 |
Prospective Analysis of Robot-Assisted Surgery |
https://ClinicalTrials.gov/show/NCT02292914 |
Recruiting |
Instituto do Cancer do Estado de São Paulo |
2020-07-10 |
| NCT02210117 |
Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02210117 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-05-21 |
| NCT02145559 |
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02145559 |
Completed |
University of Chicago |
2016-11-15 |
| NCT02141919 |
Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer |
https://ClinicalTrials.gov/show/NCT02141919 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2021-11-30 |
| NCT02141490 |
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers |
https://ClinicalTrials.gov/show/NCT02141490 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-11-20 |
| NCT02136121 |
Prospective Investigation of Robotic Single-port System |
https://ClinicalTrials.gov/show/NCT02136121 |
Completed |
Intuitive Surgical |
2013-10-31 |
| NCT02118337 |
A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT02118337 |
Completed |
MedImmune LLC |
2020-03-17 |
| NCT02111850 |
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive |
https://ClinicalTrials.gov/show/NCT02111850 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2023-12-29 |
| NCT02077933 |
Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors |
https://ClinicalTrials.gov/show/NCT02077933 |
Completed |
Novartis |
2019-04-12 |
| NCT02061605 |
First-in-Human Safety Study Of Laser Tissue Welding For Surtureless Laparoscopic Partial Nephrectomy |
https://ClinicalTrials.gov/show/NCT02061605 |
Active, not recruiting |
Laser Tissue Welding, Inc. |
2020-12-31 |
| NCT02060370 |
Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) |
https://ClinicalTrials.gov/show/NCT02060370 |
Completed |
M.D. Anderson Cancer Center |
2019-01-02 |
| NCT02035358 |
Immunotherapy Study for Metastatic Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT02035358 |
Active, not recruiting |
Lumos Pharma |
2017-01-03 |
| NCT02016391 |
Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours |
https://ClinicalTrials.gov/show/NCT02016391 |
Completed |
Uppsala University Hospital |
2014-12-31 |
| NCT01968447 |
Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex |
https://ClinicalTrials.gov/show/NCT01968447 |
Completed |
Leiden University Medical Center |
2015-10-31 |
| NCT01950923 |
Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT01950923 |
Completed |
Wake Forest University Health Sciences |
2016-03-31 |
| NCT01908166 |
Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions |
https://ClinicalTrials.gov/show/NCT01908166 |
Completed |
Stanford University |
2016-11-01 |
| NCT01896778 |
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT01896778 |
Completed |
Roswell Park Cancer Institute |
2018-02-23 |
| NCT01894607 |
Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy |
https://ClinicalTrials.gov/show/NCT01894607 |
Completed |
M.D. Anderson Cancer Center |
2014-12-31 |
| NCT01846520 |
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers |
https://ClinicalTrials.gov/show/NCT01846520 |
Completed |
City of Hope Medical Center |
2019-05-23 |
| NCT01835158 |
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT01835158 |
Active, not recruiting |
National Cancer Institute (NCI) |
2016-04-18 |
| NCT01833728 |
A Comparison of Nefopam-propacetamol Combination and Propacetamol for Postoperative Quality of Recovery After Laparoscopic Nephrectomy |
https://ClinicalTrials.gov/show/NCT01833728 |
Completed |
Yonsei University |
2014-01-31 |
| NCT01775930 |
Carfilzomib in Refractory Renal Cell Carcinoma (RCC) |
https://ClinicalTrials.gov/show/NCT01775930 |
Completed |
M.D. Anderson Cancer Center |
2019-01-18 |
| NCT01751529 |
Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer |
https://ClinicalTrials.gov/show/NCT01751529 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2015-11-30 |
| NCT01732120 |
Off Clamp Randomization |
https://ClinicalTrials.gov/show/NCT01732120 |
Active, not recruiting |
Washington University School of Medicine |
2017-05-31 |
| NCT01720706 |
Thermal Ablation in Larger Liver and Kidney Tumours |
https://ClinicalTrials.gov/show/NCT01720706 |
Completed |
University Health Network, Toronto |
2017-08-31 |
| NCT01715935 |
Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus |
https://ClinicalTrials.gov/show/NCT01715935 |
Completed |
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie |
2015-06-30 |
| NCT01688999 |
Cabozantinib for Advanced Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT01688999 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2017-12-11 |
| NCT01676428 |
A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases |
https://ClinicalTrials.gov/show/NCT01676428 |
Completed |
Peter MacCallum Cancer Centre, Australia |
2014-10-31 |
| NCT01608165 |
A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm) |
https://ClinicalTrials.gov/show/NCT01608165 |
Completed |
Newcastle-upon-Tyne Hospitals NHS Trust |
2014-10-31 |
| NCT01606787 |
Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes |
https://ClinicalTrials.gov/show/NCT01606787 |
Completed |
Memorial Sloan Kettering Cancer Center |
2018-02-28 |
| NCT01582204 |
Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01582204 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-04-30 |
| NCT01571401 |
Trying Activity in Kidney Cancer Survivors (TRACKS) Trial |
https://ClinicalTrials.gov/show/NCT01571401 |
Completed |
University of Alberta |
2012-11-30 |
| NCT01497821 |
AMG 172 First in Human Study in Patients With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT01497821 |
Completed |
Amgen |
2014-11-30 |
| NCT01497444 |
Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01497444 |
Completed |
Alliance for Clinical Trials in Oncology |
2016-01-31 |
| NCT01471002 |
Study to Evaluate the Efficacy of Percutaneous Cryoablation for Renal Tumours < 4cm in Patients Who Are Not Candidates for Partial Nephrectomy |
https://ClinicalTrials.gov/show/NCT01471002 |
Completed |
University Hospital, Strasbourg, France |
2015-12-31 |
| NCT01408004 |
Rotating Pazopanib and Everolimus to Avoid Resistance |
https://ClinicalTrials.gov/show/NCT01408004 |
Completed |
Netherlands Working Group on Immunotherapy of Oncology |
2014-04-30 |
| NCT01392183 |
Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) |
https://ClinicalTrials.gov/show/NCT01392183 |
Completed |
M.D. Anderson Cancer Center |
2019-09-08 |
| NCT00600496 |
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) |
https://ClinicalTrials.gov/show/NCT00600496 |
Active, not recruiting |
AstraZeneca |
2010-08-20 |
| NCT04393350 |
Lenvatinib and Pembrolizumab Before Surgery for the Treatment of Locally Advanced Non-Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT04393350 |
Recruiting |
Emory University |
2024-05-15 |
| NCT04337970 |
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT04337970 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-10-31 |
| NCT04322955 |
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition |
https://ClinicalTrials.gov/show/NCT04322955 |
Recruiting |
Columbia University |
2026-05-31 |
| NCT04258462 |
Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Localized Renal Tumor |
https://ClinicalTrials.gov/show/NCT04258462 |
Recruiting |
University of California, San Francisco |
2025-12-31 |
| NCT04180774 |
Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer |
https://ClinicalTrials.gov/show/NCT04180774 |
Completed |
N.N. Petrov National Medical Research Center of Oncology |
2018-12-31 |
| NCT04162834 |
Effect of Papaverine on Renal Artery Blood Flow Volume |
https://ClinicalTrials.gov/show/NCT04162834 |
Recruiting |
Asan Medical Center |
2020-10-31 |
| NCT04157985 |
Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT04157985 |
Recruiting |
University of Pittsburgh |
2021-10-31 |
| NCT04150562 |
Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma |
https://ClinicalTrials.gov/show/NCT04150562 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-08-31 |
| NCT04147494 |
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues |
https://ClinicalTrials.gov/show/NCT04147494 |
Recruiting |
Jonsson Comprehensive Cancer Center |
2030-06-01 |
| NCT04134390 |
Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study |
https://ClinicalTrials.gov/show/NCT04134390 |
Recruiting |
Spanish Oncology Genito-Urinary Group |
2022-12-31 |
| NCT04127318 |
Low-moderate Intensity Pedaling During Immunotherapy Administration |
https://ClinicalTrials.gov/show/NCT04127318 |
Enrolling by invitation |
Rush University Medical Center |
2020-10-31 |
| NCT04115254 |
Stereotactic Magnetic Resonance Guided Radiation Therapy |
https://ClinicalTrials.gov/show/NCT04115254 |
Recruiting |
Dana-Farber Cancer Institute |
2024-06-30 |
| NCT04090710 |
SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT04090710 |
Recruiting |
Ontario Clinical Oncology Group (OCOG) |
2021-12-31 |
| NCT04021238 |
Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging |
https://ClinicalTrials.gov/show/NCT04021238 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2022-05-31 |
| NCT03934827 |
MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour |
https://ClinicalTrials.gov/show/NCT03934827 |
Recruiting |
Imperial College London |
2021-08-31 |
| NCT03907657 |
Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau |
https://ClinicalTrials.gov/show/NCT03907657 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2021-07-31 |
| NCT03887091 |
Personal Web Page In Clinical Trial Participant Education |
https://ClinicalTrials.gov/show/NCT03887091 |
Completed |
Dana-Farber Cancer Institute |
2017-05-30 |
| NCT03852030 |
Mind-Body Health in Uro-Oncology: Research Study |
https://ClinicalTrials.gov/show/NCT03852030 |
Completed |
Northwestern University |
2016-07-31 |
| NCT03849820 |
Open vs Robotic Assisted Partial Nephrectomy |
https://ClinicalTrials.gov/show/NCT03849820 |
Recruiting |
Intuitive Surgical |
2021-02-28 |
| NCT03810651 |
Pencil Beam Scanning in Patients With Renal Tumors |
https://ClinicalTrials.gov/show/NCT03810651 |
Recruiting |
Children’s Hospital of Philadelphia |
2022-06-30 |
| NCT03804320 |
Protocol Active Surveillance Small Renal Masses (SRMs) |
https://ClinicalTrials.gov/show/NCT03804320 |
Recruiting |
IRCCS San Raffaele |
2023-12-11 |
| NCT03787056 |
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients |
https://ClinicalTrials.gov/show/NCT03787056 |
Recruiting |
Hospices Civils de Lyon |
2026-11-30 |
| NCT03786796 |
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations |
https://ClinicalTrials.gov/show/NCT03786796 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2021-03-31 |
| NCT03747133 |
SABR for Renal Tumors |
https://ClinicalTrials.gov/show/NCT03747133 |
Recruiting |
University Health Network, Toronto |
2020-11-30 |
| NCT03736330 |
A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma |
https://ClinicalTrials.gov/show/NCT03736330 |
Recruiting |
Sun Yat-sen University |
2020-10-08 |
| NCT03715985 |
Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac) |
https://ClinicalTrials.gov/show/NCT03715985 |
Recruiting |
Herlev Hospital |
2021-01-01 |
| NCT03693014 |
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors |
https://ClinicalTrials.gov/show/NCT03693014 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-10-31 |
| NCT03679572 |
Zero-ischemia Robot-assisted Partial Nephrectomy Using Near-infrared Fluorescence |
https://ClinicalTrials.gov/show/NCT03679572 |
Active, not recruiting |
University Hospital, Grenoble |
2020-02-10 |
| NCT03678883 |
9-ING-41 in Patients With Advanced Cancers |
https://ClinicalTrials.gov/show/NCT03678883 |
Recruiting |
Actuate Therapeutics Inc. |
2022-11-30 |
| NCT03666104 |
Using Virtual Reality (VR) Models for Preoperative Planning - Mount Sinai |
https://ClinicalTrials.gov/show/NCT03666104 |
Completed |
Ceevra, Inc. |
2019-02-28 |
| NCT03652298 |
Effects of a Neuroscience-based Technique on Post-traumatic Stress Disorder Symptoms, Inflammation, and Survival in Cancer Patients Announced of a Palliative Disease Progression and Their Partners |
https://ClinicalTrials.gov/show/NCT03652298 |
Recruiting |
Centre Oscar Lambret |
2020-05-25 |
| NCT03638206 |
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies |
https://ClinicalTrials.gov/show/NCT03638206 |
Recruiting |
Shenzhen BinDeBio Ltd. |
2023-03-01 |
| NCT03634540 |
A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) |
https://ClinicalTrials.gov/show/NCT03634540 |
Recruiting |
Peloton Therapeutics, Inc. |
2023-08-14 |
| NCT03623490 |
Optimizing the Management of Patients With Oral Therapy |
https://ClinicalTrials.gov/show/NCT03623490 |
Recruiting |
Centre Georges Francois Leclerc |
2018-05-22 |
| NCT03617913 |
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer |
https://ClinicalTrials.gov/show/NCT03617913 |
Active, not recruiting |
Mayo Clinic |
2019-11-14 |
| NCT03571438 |
Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors |
https://ClinicalTrials.gov/show/NCT03571438 |
Recruiting |
University Hospital, Grenoble |
2022-09-30 |
| NCT03556943 |
Using Virtual Reality (VR) Models for Preoperative Planning - Mayo Clinic |
https://ClinicalTrials.gov/show/NCT03556943 |
Completed |
Ceevra, Inc. |
2019-02-28 |
| NCT03556046 |
89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE |
https://ClinicalTrials.gov/show/NCT03556046 |
Completed |
Radboud University |
2018-12-17 |
| NCT03534206 |
Using Virtual Reality (VR) Models for Preoperative Planning - University of Tennessee |
https://ClinicalTrials.gov/show/NCT03534206 |
Completed |
Ceevra, Inc. |
2019-02-28 |
| NCT03522155 |
Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies |
https://ClinicalTrials.gov/show/NCT03522155 |
Recruiting |
Cedars-Sinai Medical Center |
2022-09-30 |
| NCT03520231 |
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases |
https://ClinicalTrials.gov/show/NCT03520231 |
Recruiting |
University Health Network, Toronto |
2019-12-01 |
| NCT03514550 |
Effects of Anesthesia on Immunity in Cancer |
https://ClinicalTrials.gov/show/NCT03514550 |
Completed |
Meshalkin Research Institute of Pathology of Circulation |
2019-04-01 |
| NCT03513952 |
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma |
https://ClinicalTrials.gov/show/NCT03513952 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT03473730 |
Daratumumab in Treating Patients With Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT03473730 |
Recruiting |
M.D. Anderson Cancer Center |
2021-12-31 |
| NCT03470285 |
Multiparametric MRI for Diagnosing Small Renal Tumors |
https://ClinicalTrials.gov/show/NCT03470285 |
Recruiting |
University Hospital, Bordeaux |
2021-07-31 |
| NCT03469713 |
Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03469713 |
Recruiting |
Gruppo Oncologico Italiano di Ricerca Clinica |
2019-07-14 |
| NCT03444766 |
Study of Nivolumab for Advanced Cancers in India |
https://ClinicalTrials.gov/show/NCT03444766 |
Completed |
Bristol-Myers Squibb |
2019-07-17 |
| NCT03421418 |
Using Virtual Reality (VR) Models for Preoperative Planning - UNC |
https://ClinicalTrials.gov/show/NCT03421418 |
Completed |
Ceevra, Inc. |
2019-02-28 |
| NCT01263769 |
Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC) |
https://ClinicalTrials.gov/show/NCT01263769 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-02-29 |
| NCT01218854 |
A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy |
https://ClinicalTrials.gov/show/NCT01218854 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-11-16 |
| NCT01217931 |
Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial |
https://ClinicalTrials.gov/show/NCT01217931 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-01-31 |
| NCT01191892 |
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer |
https://ClinicalTrials.gov/show/NCT01191892 |
Completed |
Cardiff University |
2015-12-31 |
| NCT01184326 |
Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT01184326 |
Completed |
Dana-Farber Cancer Institute |
2017-03-31 |
| NCT01164228 |
Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01164228 |
Active, not recruiting |
Eastern Cooperative Oncology Group |
2018-05-31 |
| NCT01154816 |
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia |
https://ClinicalTrials.gov/show/NCT01154816 |
Completed |
Children’s Oncology Group |
2015-12-31 |
| NCT01122615 |
Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) |
https://ClinicalTrials.gov/show/NCT01122615 |
Completed |
M.D. Anderson Cancer Center |
2014-07-31 |
| NCT01120249 |
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery |
https://ClinicalTrials.gov/show/NCT01120249 |
Active, not recruiting |
Southwest Oncology Group |
2021-10-31 |
| NCT01090466 |
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium |
https://ClinicalTrials.gov/show/NCT01090466 |
Completed |
Cardiff University |
2010-01-31 |
| NCT01089088 |
Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) |
https://ClinicalTrials.gov/show/NCT01089088 |
Completed |
Cardiff University |
2014-10-31 |
| NCT01038778 |
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT01038778 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-05-22 |
| NCT01034878 |
Sunitinib in Metastatic Renal Cancer |
https://ClinicalTrials.gov/show/NCT01034878 |
Completed |
Istituto Clinico Humanitas |
2014-12-31 |
| NCT01031875 |
Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment |
https://ClinicalTrials.gov/show/NCT01031875 |
Completed |
National Cancer Institute (NCI) |
2011-12-31 |
| NCT01024205 |
Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT01024205 |
Completed |
National Cancer Institute (NCI) |
2010-08-31 |
| NCT01005797 |
Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers |
https://ClinicalTrials.gov/show/NCT01005797 |
Completed |
Medical University of South Carolina |
2014-03-31 |
| NCT00979966 |
Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib |
https://ClinicalTrials.gov/show/NCT00979966 |
Completed |
Central European Society for Anticancer Drug Research |
2012-07-31 |
| NCT00967577 |
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT00967577 |
Active, not recruiting |
Weill Medical College of Cornell University |
2018-06-30 |
| NCT00945009 |
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor |
https://ClinicalTrials.gov/show/NCT00945009 |
Active, not recruiting |
Children’s Oncology Group |
2016-12-31 |
| NCT00943839 |
Sunitinib Malate in Treating Patients With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00943839 |
Completed |
Centre Antoine Lacassagne |
2014-11-30 |
| NCT00920816 |
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT00920816 |
Active, not recruiting |
Pfizer |
2012-07-27 |
| NCT00896454 |
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium |
https://ClinicalTrials.gov/show/NCT00896454 |
Completed |
Amgen |
2012-09-13 |
| NCT00888641 |
A Pilot Study of Renal Hypothermia During Partial Nephrectomy |
https://ClinicalTrials.gov/show/NCT00888641 |
Completed |
Mayo Clinic |
2011-05-31 |
| NCT00866320 |
Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab |
https://ClinicalTrials.gov/show/NCT00866320 |
Completed |
Case Comprehensive Cancer Center |
2009-12-31 |
| NCT00854620 |
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00854620 |
Completed |
Stanford University |
2009-07-31 |
| NCT00853021 |
Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney |
https://ClinicalTrials.gov/show/NCT00853021 |
Completed |
Case Comprehensive Cancer Center |
2009-10-31 |
| NCT00849186 |
Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00849186 |
Completed |
Roswell Park Cancer Institute |
2009-07-31 |
| NCT03542565 |
Using Virtual Reality (VR) Models for Preoperative Planning - JWCI |
https://ClinicalTrials.gov/show/NCT03542565 |
Completed |
Ceevra, Inc. |
2019-02-28 |
| NCT03540199 |
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT03540199 |
Recruiting |
Fuda Cancer Hospital, Guangzhou |
2020-05-20 |
| NCT02724878 |
Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02724878 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2019-11-13 |
| NCT00827359 |
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00827359 |
Completed |
Dana-Farber Cancer Institute |
2018-01-31 |
| NCT04120805 |
Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy |
https://ClinicalTrials.gov/show/NCT04120805 |
Recruiting |
University of Chicago |
2022-03-01 |
| NCT02849535 |
Impact of the PRISM-care Multidisciplinary Oncology Program on Secured Drug Intake of Patients With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT02849535 |
Recruiting |
Hospices Civils de Lyon |
2021-04-30 |
| NCT03983954 |
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT03983954 |
Recruiting |
NeoTX Therapeutics Ltd. |
2021-11-01 |
| NCT00814021 |
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain |
https://ClinicalTrials.gov/show/NCT00814021 |
Completed |
Institut Claudius Regaud |
2010-12-31 |
| NCT00807339 |
CyberKnife for Unresectable Renal Tumors |
https://ClinicalTrials.gov/show/NCT00807339 |
Completed |
Beth Israel Deaconess Medical Center |
2014-01-01 |
| NCT03308396 |
Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT03308396 |
Recruiting |
Big Ten Cancer Research Consortium |
2019-12-01 |
| NCT03244384 |
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT03244384 |
Recruiting |
National Cancer Institute (NCI) |
2025-06-01 |
| NCT02437370 |
Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT02437370 |
Recruiting |
University of California, Davis |
2020-06-30 |
| NCT03755739 |
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors for Immunotherapy of Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03755739 |
Recruiting |
Second Affiliated Hospital of Guangzhou Medical University |
2033-11-01 |
| NCT01012427 |
Percutaneous Renal Tumor Cryoablation Followed by Biopsy |
https://ClinicalTrials.gov/show/NCT01012427 |
Completed |
Memorial Sloan Kettering Cancer Center |
2015-09-30 |
| NCT00792025 |
Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer |
https://ClinicalTrials.gov/show/NCT00792025 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00782275 |
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00782275 |
Completed |
Dana-Farber Cancer Institute |
2015-05-31 |
| NCT00749892 |
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT00749892 |
Completed |
M.D. Anderson Cancer Center |
2019-06-30 |
| NCT00743236 |
Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00743236 |
Completed |
Wake Forest University Health Sciences |
2009-06-30 |
| NCT00729053 |
Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma |
https://ClinicalTrials.gov/show/NCT00729053 |
Completed |
Idera Pharmaceuticals, Inc. |
2008-04-30 |
| NCT00722228 |
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors |
https://ClinicalTrials.gov/show/NCT00722228 |
Recruiting |
Hadassah Medical Organization |
2021-01-31 |
| NCT00688753 |
RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe |
https://ClinicalTrials.gov/show/NCT00688753 |
Completed |
Novartis |
2014-10-31 |
| NCT00678392 |
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT00678392 |
Completed |
Pfizer |
2010-08-31 |
| NCT00671411 |
Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast |
https://ClinicalTrials.gov/show/NCT00671411 |
Completed |
Memorial Sloan Kettering Cancer Center |
2011-11-30 |
| NCT00659568 |
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma |
https://ClinicalTrials.gov/show/NCT00659568 |
Completed |
National Cancer Institute (NCI) |
2010-02-28 |
| NCT00656734 |
Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. |
https://ClinicalTrials.gov/show/NCT00656734 |
Completed |
Bristol-Myers Squibb |
2010-06-30 |
| NCT00623064 |
Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer |
https://ClinicalTrials.gov/show/NCT00623064 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2012-06-30 |
| NCT00622674 |
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00622674 |
Completed |
Masonic Cancer Center, University of Minnesota |
2009-08-31 |
| NCT00620295 |
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00620295 |
Completed |
Masonic Cancer Center, University of Minnesota |
2009-02-28 |
| NCT00606632 |
Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody |
https://ClinicalTrials.gov/show/NCT00606632 |
Completed |
Wilex |
2009-11-30 |
| NCT00588913 |
Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases |
https://ClinicalTrials.gov/show/NCT00588913 |
Completed |
National Cancer Institute (NCI) |
2009-03-31 |
| NCT00588276 |
Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors |
https://ClinicalTrials.gov/show/NCT00588276 |
Completed |
Memorial Sloan Kettering Cancer Center |
2012-06-30 |
| NCT00581815 |
Spectroscopy With Surface Coils and Decoupling |
https://ClinicalTrials.gov/show/NCT00581815 |
Completed |
Memorial Sloan Kettering Cancer Center |
2014-02-28 |
| NCT00579514 |
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients |
https://ClinicalTrials.gov/show/NCT00579514 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-03-31 |
| NCT00566995 |
Phase II Study of Vandetanib in Individuals With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00566995 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-06-20 |
| NCT00550277 |
LBH589 Treatment for Refractory Clear Cell Renal Carcinoma |
https://ClinicalTrials.gov/show/NCT00550277 |
Completed |
SCRI Development Innovations, LLC |
2010-03-31 |
| NCT00537056 |
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI |
https://ClinicalTrials.gov/show/NCT00537056 |
Completed |
Stanford University |
2011-10-31 |
| NCT00531284 |
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma |
https://ClinicalTrials.gov/show/NCT00531284 |
Completed |
Amgen |
2014-10-31 |
| NCT00514215 |
Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer |
https://ClinicalTrials.gov/show/NCT00514215 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2010-03-31 |
| NCT00505310 |
Biobehavioral Effects of Emotional Expression in Cancer |
https://ClinicalTrials.gov/show/NCT00505310 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-08-31 |
| NCT00498966 |
Ph II Study of Perifosine for Patients With Carcinoma of the Kidney |
https://ClinicalTrials.gov/show/NCT00498966 |
Completed |
AEterna Zentaris |
2011-07-31 |
| NCT00496587 |
Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00496587 |
Completed |
M.D. Anderson Cancer Center |
2016-05-31 |
| NCT00492258 |
Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00492258 |
Completed |
National Cancer Institute (NCI) |
2012-08-31 |
| NCT00490698 |
Zoledronate With Atorvastatin in Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00490698 |
Completed |
M.D. Anderson Cancer Center |
2012-01-31 |
| NCT00478361 |
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function |
https://ClinicalTrials.gov/show/NCT00478361 |
Completed |
M.D. Anderson Cancer Center |
2015-06-30 |
| NCT00471432 |
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors |
https://ClinicalTrials.gov/show/NCT00471432 |
Completed |
Canadian Cancer Trials Group |
2006-03-09 |
| NCT00465179 |
Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT00465179 |
Completed |
M.D. Anderson Cancer Center |
2015-03-31 |
| NCT00462982 |
Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma |
https://ClinicalTrials.gov/show/NCT00462982 |
Completed |
Memorial Sloan Kettering Cancer Center |
2008-08-31 |
| NCT00459979 |
Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00459979 |
Completed |
Case Comprehensive Cancer Center |
2011-03-31 |
| NCT00459875 |
Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00459875 |
Completed |
Memorial Sloan Kettering Cancer Center |
2010-11-30 |
| NCT00458536 |
Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF |
https://ClinicalTrials.gov/show/NCT00458536 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2014-12-31 |
| NCT00458484 |
Radiosurgery in Treating Patients With Kidney Tumors |
https://ClinicalTrials.gov/show/NCT00458484 |
Active, not recruiting |
Case Comprehensive Cancer Center |
2019-08-26 |
| NCT00455975 |
High-dose Bevacizumab in Advanced Renal Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT00455975 |
Completed |
SCRI Development Innovations, LLC |
2013-07-31 |
| NCT00019630 |
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00019630 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00441337 |
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies |
https://ClinicalTrials.gov/show/NCT00441337 |
Completed |
Bristol-Myers Squibb |
2009-11-30 |
| NCT00425386 |
Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00425386 |
Completed |
OHSU Knight Cancer Institute |
2010-08-31 |
| NCT00422344 |
A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00422344 |
Completed |
Memorial Sloan Kettering Cancer Center |
2010-02-28 |
| NCT00421512 |
A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT00421512 |
Completed |
Memorial Sloan Kettering Cancer Center |
2008-05-31 |
| NCT00418496 |
Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00418496 |
Completed |
Ohio State University Comprehensive Cancer Center |
2013-02-28 |
| NCT00416871 |
Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00416871 |
Completed |
Centre Leon Berard |
NA |
| NCT00416429 |
Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00416429 |
Completed |
Centre Leon Berard |
NA |
| NCT00407485 |
VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium |
https://ClinicalTrials.gov/show/NCT00407485 |
Completed |
National Cancer Institute (NCI) |
2010-04-30 |
| NCT00405366 |
Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00405366 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2009-06-30 |
| NCT00403169 |
Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00403169 |
Completed |
The Cleveland Clinic |
2009-05-31 |
| NCT00401128 |
Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00401128 |
Completed |
The Cleveland Clinic |
2007-02-28 |
| NCT00399152 |
Perifosine + Sunitinib Malate for Patients With Advanced Cancers |
https://ClinicalTrials.gov/show/NCT00399152 |
Completed |
AEterna Zentaris |
2008-12-31 |
| NCT00398814 |
Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers |
https://ClinicalTrials.gov/show/NCT00398814 |
Completed |
AEterna Zentaris |
2011-09-30 |
| NCT00397488 |
Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium |
https://ClinicalTrials.gov/show/NCT00397488 |
Completed |
Memorial Sloan Kettering Cancer Center |
2012-02-29 |
| NCT00397345 |
TroVax Renal Immunotherapy Survival Trial |
https://ClinicalTrials.gov/show/NCT00397345 |
Completed |
Oxford BioMedica |
2009-12-31 |
| NCT00392821 |
Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00392821 |
Completed |
SCRI Development Innovations, LLC |
2013-10-31 |
| NCT00381173 |
A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing |
https://ClinicalTrials.gov/show/NCT00381173 |
Completed |
Eisai Inc. |
2008-10-31 |
| NCT00375674 |
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT00375674 |
Completed |
Pfizer |
2016-04-07 |
| NCT00369564 |
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00369564 |
Completed |
University of South Florida |
2012-11-30 |
| NCT00365768 |
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors |
https://ClinicalTrials.gov/show/NCT00365768 |
Completed |
Columbia University |
2012-06-30 |
| NCT00365287 |
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00365287 |
Completed |
Masonic Cancer Center, University of Minnesota |
2005-12-31 |
| NCT00335556 |
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors |
https://ClinicalTrials.gov/show/NCT00335556 |
Completed |
Children’s Oncology Group |
2015-12-31 |
| NCT00331409 |
Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00331409 |
Completed |
OHSU Knight Cancer Institute |
2010-01-31 |
| NCT00323739 |
Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma |
https://ClinicalTrials.gov/show/NCT00323739 |
Completed |
SCRI Development Innovations, LLC |
2008-11-30 |
| NCT00316901 |
Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial |
https://ClinicalTrials.gov/show/NCT00316901 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-12-31 |
| NCT00310011 |
Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium |
https://ClinicalTrials.gov/show/NCT00310011 |
Completed |
Wake Forest University Health Sciences |
2005-10-31 |
| NCT00303732 |
Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00303732 |
Completed |
Duke University |
2010-08-31 |
| NCT00301847 |
Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain |
https://ClinicalTrials.gov/show/NCT00301847 |
Completed |
National Cancer Institute (NCI) |
2007-06-30 |
| NCT00282048 |
Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT00282048 |
Completed |
Pfizer |
2009-02-28 |
| NCT00278369 |
Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer |
https://ClinicalTrials.gov/show/NCT00278369 |
Completed |
Northwestern University |
2009-06-30 |
| NCT00278174 |
Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00278174 |
Completed |
Case Comprehensive Cancer Center |
2007-04-30 |
| NCT00276835 |
Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00276835 |
Completed |
Northwestern University |
2007-07-31 |
| NCT00276614 |
Bortezomib in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00276614 |
Completed |
Jonsson Comprehensive Cancer Center |
2009-07-31 |
| NCT00276536 |
Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma |
https://ClinicalTrials.gov/show/NCT00276536 |
Completed |
The Cleveland Clinic |
2004-01-31 |
| NCT00262886 |
Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00262886 |
Completed |
University of Rochester |
2007-07-31 |
| NCT00241163 |
TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN) |
https://ClinicalTrials.gov/show/NCT00241163 |
Completed |
Takeda |
NA |
| NCT00226980 |
A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00226980 |
Completed |
Stanford University |
2005-07-31 |
| NCT00199888 |
Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. |
https://ClinicalTrials.gov/show/NCT00199888 |
Completed |
Ludwig Institute for Cancer Research |
NA |
| NCT00199875 |
Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 |
https://ClinicalTrials.gov/show/NCT00199875 |
Completed |
Ludwig Institute for Cancer Research |
2013-03-14 |
| NCT00193154 |
OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00193154 |
Completed |
SCRI Development Innovations, LLC |
2004-01-31 |
| NCT00142415 |
Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer |
https://ClinicalTrials.gov/show/NCT00142415 |
Completed |
Ludwig Institute for Cancer Research |
2011-01-31 |
| NCT00134186 |
Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer |
https://ClinicalTrials.gov/show/NCT00134186 |
Completed |
Pharmacyclics LLC. |
NA |
| NCT00123773 |
Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence |
https://ClinicalTrials.gov/show/NCT00123773 |
Completed |
AHS Cancer Control Alberta |
2008-12-31 |
| NCT00118326 |
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease |
https://ClinicalTrials.gov/show/NCT00118326 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00113217 |
Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00113217 |
Completed |
M.D. Anderson Cancer Center |
2012-08-31 |
| NCT00112671 |
Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract |
https://ClinicalTrials.gov/show/NCT00112671 |
Completed |
National Cancer Institute (NCI) |
2010-05-31 |
| NCT00101608 |
Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium |
https://ClinicalTrials.gov/show/NCT00101608 |
Completed |
Bristol-Myers Squibb |
2007-04-30 |
| NCT00100906 |
Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT00100906 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2006-06-30 |
| NCT00098943 |
NGR-TNF in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00098943 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2007-11-30 |
| NCT00096629 |
Vaccine Therapy in Treating Patients With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00096629 |
Completed |
Memorial Sloan Kettering Cancer Center |
2018-04-30 |
| NCT00096525 |
Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00096525 |
Completed |
Memorial Sloan Kettering Cancer Center |
2005-08-31 |
| NCT00095108 |
Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00095108 |
Completed |
ZymoGenetics |
2007-01-31 |
| NCT00093405 |
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00093405 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003551 |
Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003551 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003390 |
6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003390 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003102 |
Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003102 |
Completed |
Ludwig Institute for Cancer Research |
2000-08-31 |
| NCT00002914 |
Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract |
https://ClinicalTrials.gov/show/NCT00002914 |
Completed |
Eastern Cooperative Oncology Group |
2001-06-30 |
| NCT00005056 |
Bryostatin 1 In Treating Patients With Progressive Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00005056 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003542 |
Interferon Alfa in Treating Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003542 |
Completed |
Memorial Sloan Kettering Cancer Center |
2004-04-30 |
| NCT00088374 |
17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease |
https://ClinicalTrials.gov/show/NCT00088374 |
Completed |
National Institutes of Health Clinical Center (CC) |
2009-01-31 |
| NCT00003585 |
Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003585 |
Completed |
University of New Mexico |
2001-08-31 |
| NCT00087022 |
Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00087022 |
Completed |
Wilex |
2012-10-31 |
| NCT00003091 |
High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma |
https://ClinicalTrials.gov/show/NCT00003091 |
Completed |
Hoag Memorial Hospital Presbyterian |
2000-01-31 |
| NCT00002733 |
Biological Therapy in Treating Patients With Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00002733 |
Completed |
Hoag Memorial Hospital Presbyterian |
2000-01-31 |
| NCT00085436 |
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC |
https://ClinicalTrials.gov/show/NCT00085436 |
Completed |
Dartmouth-Hitchcock Medical Center |
2009-10-31 |
| NCT00005045 |
Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00005045 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003584 |
Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003584 |
Completed |
University of New Mexico |
2000-12-31 |
| NCT00005069 |
Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00005069 |
Completed |
Memorial Sloan Kettering Cancer Center |
2001-07-31 |
| NCT00004880 |
Vaccine Therapy in Treating Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00004880 |
Completed |
Jonsson Comprehensive Cancer Center |
2001-04-30 |
| NCT00082914 |
Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00082914 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002737 |
Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00002737 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-01-31 |
| NCT00003968 |
Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003968 |
Completed |
National Cancer Institute (NCI) |
2003-12-31 |
| NCT00003175 |
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00003175 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003133 |
Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00003133 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-01-31 |
| NCT00006483 |
Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung |
https://ClinicalTrials.gov/show/NCT00006483 |
Completed |
Alliance for Clinical Trials in Oncology |
2003-01-31 |
| NCT00003914 |
Dolastatin 10 in Treating Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003914 |
Completed |
Mayo Clinic |
2002-08-31 |
| NCT00002764 |
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00002764 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-11-30 |
| NCT00003376 |
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium |
https://ClinicalTrials.gov/show/NCT00003376 |
Completed |
Eastern Cooperative Oncology Group |
2005-09-30 |
| NCT00080873 |
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00080873 |
Completed |
Children’s Oncology Group |
2006-11-30 |
| NCT00080795 |
Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium |
https://ClinicalTrials.gov/show/NCT00080795 |
Completed |
M.D. Anderson Cancer Center |
2006-05-31 |
| NCT00003103 |
Chemotherapy in Treating Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00003103 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-08-31 |
| NCT00020540 |
Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00020540 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00006376 |
R115777 in Treating Patients With Advanced Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00006376 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005816 |
Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00005816 |
Completed |
Duke University |
NA |
| NCT00006026 |
Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract |
https://ClinicalTrials.gov/show/NCT00006026 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-10-31 |
| NCT00004223 |
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00004223 |
Completed |
Eastern Cooperative Oncology Group |
2002-10-31 |
| NCT00021021 |
RPI.4610 in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00021021 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005995 |
AE-941 in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00005995 |
Completed |
AEterna Zentaris |
2007-03-31 |
| NCT00004203 |
Oxaliplatin in Treating Patients With Metastatic Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00004203 |
Completed |
University of Chicago |
2002-02-28 |
| NCT00077129 |
Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT00077129 |
Completed |
Eastern Cooperative Oncology Group |
2006-08-31 |
| NCT00076011 |
Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00076011 |
Completed |
Pfizer |
2007-02-28 |
| NCT00075660 |
3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00075660 |
Completed |
Canadian Cancer Trials Group |
2005-10-04 |
| NCT00016237 |
Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment |
https://ClinicalTrials.gov/show/NCT00016237 |
Completed |
EMD Serono |
NA |
| NCT00014183 |
ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00014183 |
Completed |
University of Maryland, Baltimore |
2002-05-31 |
| NCT00006384 |
SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00006384 |
Completed |
City of Hope Medical Center |
2007-02-28 |
| NCT00004890 |
Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00004890 |
Completed |
National Cancer Institute (NCI) |
2002-12-31 |
| NCT00073879 |
Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00073879 |
Completed |
Baylor College of Medicine |
2004-04-30 |
| NCT00072150 |
Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00072150 |
Completed |
National Cancer Institute (NCI) |
2006-03-31 |
| NCT00072046 |
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) |
https://ClinicalTrials.gov/show/NCT00072046 |
Completed |
Alliance for Clinical Trials in Oncology |
2004-01-31 |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00014144 |
S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract |
https://ClinicalTrials.gov/show/NCT00014144 |
Completed |
Southwest Oncology Group |
2003-05-31 |
| NCT00021099 |
Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00021099 |
Completed |
National Cancer Institute (NCI) |
2007-08-31 |
| NCT00069160 |
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer |
https://ClinicalTrials.gov/show/NCT00069160 |
Completed |
National Institutes of Health Clinical Center (CC) |
2009-12-31 |
| NCT00016939 |
Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00016939 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00011973 |
Chemotherapy in Treating Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00011973 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2005-10-31 |
| NCT00005027 |
Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00005027 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2005-03-31 |
| NCT00066612 |
S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy |
https://ClinicalTrials.gov/show/NCT00066612 |
Completed |
Southwest Oncology Group |
2007-08-31 |
| NCT00066352 |
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter |
https://ClinicalTrials.gov/show/NCT00066352 |
Completed |
University Health Network, Toronto |
2003-09-30 |
| NCT00065468 |
Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00065468 |
Completed |
Pfizer |
2006-06-30 |
| NCT00006968 |
Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00006968 |
Completed |
Jonsson Comprehensive Cancer Center |
2004-09-30 |
| NCT00025376 |
PS-341 in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00025376 |
Completed |
University of Chicago |
2002-09-30 |
| NCT00006864 |
Interleukin-2 in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00006864 |
Completed |
Case Comprehensive Cancer Center |
2007-07-31 |
| NCT00059735 |
A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT00059735 |
Completed |
Eisai Inc. |
NA |
| NCT00004095 |
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT00004095 |
Completed |
Northwestern University |
2008-10-31 |
| NCT00018941 |
Interleukin-2 in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00018941 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00058318 |
S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer |
https://ClinicalTrials.gov/show/NCT00058318 |
Completed |
Southwest Oncology Group |
2007-05-31 |
| NCT00057889 |
Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer |
https://ClinicalTrials.gov/show/NCT00057889 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-10-31 |
| NCT00056537 |
ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT00056537 |
Completed |
Active Biotech AB |
2006-12-31 |
| NCT00056095 |
Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00056095 |
Completed |
UNICANCER |
2008-02-13 |
| NCT00054886 |
Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00054886 |
Completed |
Pfizer |
NA |
| NCT00053820 |
Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00053820 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00053807 |
Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00053807 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2004-01-31 |
| NCT00053209 |
Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium |
https://ClinicalTrials.gov/show/NCT00053209 |
Completed |
Eastern Cooperative Oncology Group |
2007-09-30 |
| NCT00045630 |
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium |
https://ClinicalTrials.gov/show/NCT00045630 |
Completed |
Southwest Oncology Group |
2008-05-31 |
| NCT00045487 |
Erlotinib in Treating Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00045487 |
Completed |
The University of Texas Health Science Center at San Antonio |
2008-05-31 |
| NCT00045370 |
Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00045370 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-11-30 |
| NCT00045279 |
PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00045279 |
Completed |
Memorial Sloan Kettering Cancer Center |
2005-09-30 |
| NCT00042965 |
Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00042965 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-09-30 |
| NCT00041106 |
Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00041106 |
Completed |
National Cancer Institute (NCI) |
2007-07-31 |
| NCT00039429 |
Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00039429 |
Completed |
Eastern Cooperative Oncology Group |
2006-04-30 |
| NCT00039052 |
Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer |
https://ClinicalTrials.gov/show/NCT00039052 |
Completed |
National Cancer Institute (NCI) |
2003-05-31 |
| NCT00031564 |
Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 |
https://ClinicalTrials.gov/show/NCT00031564 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2005-06-30 |
| NCT00030342 |
Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00030342 |
Completed |
National Cancer Institute (NCI) |
2007-10-31 |
| NCT00028860 |
Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00028860 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00027573 |
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00027573 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-06-30 |
| NCT00022191 |
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00022191 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2004-06-30 |
| NCT00020527 |
Caspofungin Acetate in Treating Children With Fever and Neutropenia |
https://ClinicalTrials.gov/show/NCT00020527 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019955 |
Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer) |
https://ClinicalTrials.gov/show/NCT00019955 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00017329 |
PS-341 in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00017329 |
Completed |
National Cancer Institute (NCI) |
2004-04-30 |
| NCT00014274 |
Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium |
https://ClinicalTrials.gov/show/NCT00014274 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2008-03-31 |
| NCT00006351 |
SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract |
https://ClinicalTrials.gov/show/NCT00006351 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-12-31 |
| NCT00006255 |
Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases |
https://ClinicalTrials.gov/show/NCT00006255 |
Completed |
Case Comprehensive Cancer Center |
2005-03-31 |
| NCT00006022 |
Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00006022 |
Completed |
Virginia Commonwealth University |
2003-10-31 |
| NCT00005966 |
Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00005966 |
Completed |
National Cancer Institute (NCI) |
2006-03-31 |
| NCT00005831 |
Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00005831 |
Completed |
National Cancer Institute (NCI) |
2004-08-31 |
| NCT00005644 |
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function |
https://ClinicalTrials.gov/show/NCT00005644 |
Completed |
Eastern Cooperative Oncology Group |
2003-02-28 |
| NCT00004879 |
Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer |
https://ClinicalTrials.gov/show/NCT00004879 |
Completed |
Jonsson Comprehensive Cancer Center |
2005-07-31 |
| NCT00004244 |
Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma |
https://ClinicalTrials.gov/show/NCT00004244 |
Completed |
National Cancer Institute (NCI) |
2005-07-31 |
| NCT00004135 |
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00004135 |
Completed |
University of Chicago |
2004-10-31 |
| NCT00003928 |
Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003928 |
Completed |
Case Comprehensive Cancer Center |
2005-02-28 |
| NCT00003656 |
Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003656 |
Completed |
Weill Medical College of Cornell University |
2008-05-31 |
| NCT00003553 |
Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003553 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-06-27 |
| NCT00003342 |
Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003342 |
Completed |
Memorial Sloan Kettering Cancer Center |
2007-07-31 |
| NCT00003308 |
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma |
https://ClinicalTrials.gov/show/NCT00003308 |
Completed |
Eastern Cooperative Oncology Group |
2004-09-30 |
| NCT00003105 |
Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00003105 |
Completed |
Memorial Sloan Kettering Cancer Center |
2004-08-31 |
| NCT00002641 |
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00002641 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2006-02-28 |
| NCT00002611 |
Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00002611 |
Completed |
Children’s Oncology Group |
2002-06-30 |
| NCT00002610 |
Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors |
https://ClinicalTrials.gov/show/NCT00002610 |
Completed |
Children’s Oncology Group |
2002-06-30 |
| NCT00002475 |
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00002475 |
Completed |
National Cancer Institute (NCI) |
2007-12-31 |
| NCT00002473 |
Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00002473 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2011-02-28 |
| NCT00001570 |
A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer |
https://ClinicalTrials.gov/show/NCT00001570 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00035243 |
EPO906 Therapy in Patients With Advanced Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00035243 |
Completed |
Novartis |
2003-08-31 |
| NCT00034281 |
Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 |
https://ClinicalTrials.gov/show/NCT00034281 |
Completed |
Takeda |
2003-09-30 |
| NCT00328861 |
Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00328861 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-07-31 |
| NCT00012337 |
ZD 1839 in Treating Patients With Metastatic Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00012337 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003126 |
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00003126 |
Completed |
Loyola University |
2002-08-31 |
| NCT00001302 |
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 |
https://ClinicalTrials.gov/show/NCT00001302 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |